Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2010
10/20/2010EP1366366B1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
10/20/2010CN101868540A Vaccine for swine edema disease
10/20/2010CN101868478A Inhibition of macrophage-stimulating protein receptor (RON) and methods of treatment thereof
10/20/2010CN101868474A Poxviral oncolytic vectors
10/20/2010CN101868250A Composition containing hcmv particles
10/20/2010CN101868249A Medicaments and methods for treating mesothelioma
10/20/2010CN101868248A Fish vaccine
10/20/2010CN101868247A Pharmaceuticals compositions comprising actinomycete glycerol acyl derivatives antigens, their process of extraction, and their use against tuberculosis
10/20/2010CN101864434A Sheep aphthovirus Asial type multi-epitope recombinant vaccine and preparation method thereof
10/20/2010CN101864399A Enterovirus and application thereof
10/20/2010CN101864398A Monoclonal antibody of anti-gonadotropin-releasing hormone receptor and application thereof
10/20/2010CN101863984A Prostatic cancer therapeutic vaccine modified on surface of GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor)/TNF (Tumor Necrosis Factor)-alpha membrane
10/20/2010CN101863978A Human source anti-rabies virus Fab antibody, cross linking method thereof with nanometer particles and application thereof
10/20/2010CN101863973A Recombinant human FSHR-57 polypeptide protein and preparation method and application thereof
10/20/2010CN101863970A Anti-Pf332-DBL region monoclonal antibody capable of restraining invasion of plasmodiumfalciparum
10/20/2010CN101863965A Helicobacter pylori urease B antigenic epitope polypeptide and application thereof
10/20/2010CN101863964A Helicobacter pylori urease B antigen epitope polypeptide and application thereof
10/20/2010CN101863963A Helicobacter pylori antigen epitope polypeptide and application thereof
10/20/2010CN101863930A Certain aminoalkyl glucosaminide phosphate compounds and their use
10/20/2010CN101862452A Method for preparing swine multi-valent antiserum compound preparation
10/20/2010CN101862451A Improvements relating to meningococcal outer membrane vesicles
10/20/2010CN101862450A Recombinant bacillus calmette-guerin vaccine secreting bacteria resuscitation somatomedin and application thereof
10/20/2010CN101862449A Compositions and methods for treatment of candidiasis
10/20/2010CN101862448A Immune protection effect of AFP (Alpha Fetoprotein) gene modified dendritic cell tumor vaccine to primary liver cancer genesis and development
10/20/2010CN101862308A Aeromonas hydrophila micro-capsular oral vaccine
10/20/2010CN101376887B Preparation and use of swine foot-and-mouth disease recombinant immune composite peptide
10/19/2010US7816578 produces antibodies comprising two human immunoglobulin loci for use in the treatmnent of cardiovascular, infections, cancer and autoimmune disorders
10/19/2010US7816511 Screening drugs; prevent gene expression; monitoring cardiovascular disorders
10/19/2010US7816508 DNA active as a modified vaccinia virus Ankara promoter or active as a promoter in vaccinia virus infected cells; expression cassettes having coding sequence codes for therapeutic proteins or peptides, antigens, antigenic epitopes, antisense RNA or ribozymes; vaccines; genetic vectors; avipoxviruses;
10/19/2010US7816496 Carbonic anhydrase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
10/19/2010US7816494 Fibrinogen binding protein for use in diagnosis, prevention and treatment of Staphylococcal infection; bactericides; wound healing agents
10/19/2010US7816334 Nucleic acid construct and nucleic acid expression vectors directing expression of a fusion protein consisting of a disease peptide antigen and a first domain of FrC of tetanus toxin; vaccines
10/19/2010US7816325 secondary binding site of dipeptidyl peptidase IV, its relationship amongst substrates and to the modulation of substrate specificity of dipeptidyl peptidase IV (DP IV, synonym: DPP IV, CD26, EC 3.4.14.5). The application relates further to compounds that bind to the secondary binding site of DP IV
10/19/2010US7816322 Stabilizing dystrophin associated protein complexes on cell surfaces; utilizing polypeptide related to amino acids 38-365 of sequence 9; muscular dystrophies; neuromuscular and neurological disorders
10/19/2010US7816320 point mutations with p-acetyl phenylalanine; covalently linked to poly(ethylene glycol); histidine buffer
10/19/2010US7816319 Methods and products for manipulating uncoupling protein expression
10/19/2010US7816134 Method of extensive culture of antigen-specific cytotoxic T cells
10/19/2010US7816118 Methods for the in vitro culture of Sporozoea sp. and uses thereof
10/19/2010US7816087 Gene expressed in prostate cancer and methods of use
10/19/2010US7816086 Genes of an otitis media isolate of nontypeable Haemophilus influenzae
10/19/2010US7816076 Therapeutic targets in cancer
10/19/2010US7815943 Blood flow enhancer and inflamation reducer, anticholesterol agents and oxidation reduction
10/19/2010US7815941 Nucleic acid microspheres, production and delivery thereof
10/19/2010US7815927 biocompatible time-release coatings comprised of acrylate and vinyl monomers containing drugs, on the surfaces of implantable medical equipment
10/19/2010US7815920 Method of preparing an antigen-containing formulation
10/19/2010US7815919 nucleic acids encoding fungal polypeptides for assessing fungus-induced inflammation, assessing eosinophil degranulation, and identifying inhibitors of fungus-induced inflammation and/or eosinophil degranulation
10/19/2010US7815918 Pneumococcal surface protein A for use in diagnosis, prevention and treatment of pneumocystis infection
10/19/2010US7815917 Botulinum neurotoxin serotype B activatable Botulinum neurotoxin serotype Bs
10/19/2010US7815916 Using human T cell leukemia virus type III (HTLV-III) RNA to diagnose, treat and prevent infection by human aquired immunodeficiency virus; viricides
10/19/2010US7815915 Mixture of human papillomavirus virus-like particles
10/19/2010US7815914 methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; provides for reovirus treatment of mammals to treat proliferative disorders including breast tumors, a subset of tumors in which mutation of ras gene is not believed to play significant role
10/19/2010US7815913 Chimeric tymovirus-like particles and process thereof
10/19/2010US7815911 Compositions and methods for treating Yersinia pestis infection
10/19/2010US7815910 Antigen and adjuvant of immunity, a surfactant, or a mixture of surfactants, having an overall HLB number of between 5 and 15; for application orally, nasally, rectally, or vaginally
10/19/2010US7815909 human tumor necrosis factor alpha (TNF) inhibitors; for rheumatoid arthritis, psoriatic arthritis or ankylosing spondilitis
10/19/2010US7815908 antibody that binds the same epitope of alpha v beta 5 as bound by ALULA ; Pulmonary edema
10/19/2010US7815907 Antibodies to insulin-like growth factor I receptor
10/19/2010US7815906 Compositions and methods for restoring sensitivity to treatment with HER2 antagonists
10/19/2010US7815905 Methods of increasing insulin sensitivity or decreasing insulin secretion by administering corticotropin releasing factor receptor-2 inhibitors
10/19/2010US7815904 Administration of an activated form of ultra-low doses of antibodies to an antigen, obtained using homeopathic techniques; drug dependence/drug withdrawal; side effect reduction
10/19/2010US7815896 Type III secretion pathway in Aeromonas salmonicida and uses therefor
10/19/2010CA2479747C Cotton rat lung cells for virus culture
10/19/2010CA2429544C In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
10/19/2010CA2366896C Method for the purification, recovery, and sporulation of cysts and oocysts
10/19/2010CA2337618C Chicken anaemia viruses of low pathogenicity
10/19/2010CA2309115C Use of cytokines and mitogens to inhibit pathological immune responses
10/19/2010CA2307842C Hyaluronan synthase gene and uses thereof
10/19/2010CA2241179C Dry compositions
10/19/2010CA2186118C Compacted nucleic acids and their delivery to cells
10/19/2010CA2177249C Abundant extracellular products and methods for their production and use
10/19/2010CA2174559C Antibody to aminoterminal propeptide of type 1 procollagen, and assay method using it
10/19/2010CA2165393C Anti-bordetella acellular vaccine
10/19/2010CA2147499C Prostate-specific membrane antigen
10/14/2010WO2010118424A2 Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines
10/14/2010WO2010118324A2 Antibodies against fatty acid synthase
10/14/2010WO2010118265A1 Non-pegylated liposomal doxorubicin triple combination therapy
10/14/2010WO2010118252A1 Alphavirus replicon particles expressing trp2
10/14/2010WO2010118244A1 Alphavirus Replicon Particles Expressing TRP2
10/14/2010WO2010118203A2 Endosialin binding molecules
10/14/2010WO2010117984A1 Novel strategies for improved cancer vaccines
10/14/2010WO2010117848A1 Cytokines and neuroantigens for treatment of immune disorders
10/14/2010WO2010117786A1 Influenza virus vaccines and uses thereof
10/14/2010WO2010117768A1 Prostatitis-associated antigens and methods of use thereof
10/14/2010WO2010117760A2 Fusion proteins comprising canine fc portions
10/14/2010WO2010117715A1 Malignant precursor cells from ductal carcinoma in situ lesions
10/14/2010WO2010117455A2 Human monoclonal antibodies protective against bubonic plaque
10/14/2010WO2010117325A1 New methods for treatment of inflammatory diseases
10/14/2010WO2010117059A1 Therapeutic agent for diseases in which neoplastic proliferation of plasma cells occurs
10/14/2010WO2010117057A1 Method for treatment of blood tumor using anti-tim-3 antibody
10/14/2010WO2010117011A1 ANTI-Siglec-15 ANTIBODY
10/14/2010WO2010116899A1 Phosphorylation-inhibiting agent or dephosphorylating agent for pten
10/14/2010WO2010116669A1 Tumor immunity inducer
10/14/2010WO2010116123A1 Antibodies against il-17br
10/14/2010WO2010116096A1 Method for purifying the rabies virus
10/14/2010WO2010115989A1 Diagnostic mycobacterium tuberculosis test
10/14/2010WO2010115932A1 Combination for the treatment of bone loss
10/14/2010WO2010115843A2 Pharmaceutical composition
10/14/2010WO2010115589A1 Trivalent, bispecific antibodies
10/14/2010WO2010115554A1 Combination therapy of an afucosylated antibody and one or more of the cytokines selected from human gm-csf, human m-csf and/or human il-3
10/14/2010WO2010115551A1 Bispecific anti-erbb-1/anti-c-met antibodies
1 ... 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 ... 1823